SURIvsETF 2ETF Comparison
VS
Choose a second ETF to run a side-by-side ETF comparison with SURI, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
SURI performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 10/27/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | SURI ETF 2 | -3.46%– | -1.37%– | +13.74%– | +14.65%– | +51.51%– | n/a– |
| Flows | SURI ETF 2 | +$695K– | +$1M– | -$2M– | -$2M– | -$1M– | -– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | SURI ETF 2 | +20.36%– | +24.13%– | +28.62%– | n/a– |
| Max drawdown | SURI ETF 2 | -16.76%– | -16.76%– | -45.89%– | n/a– |
| Max drawdown duration | SURI ETF 2 | 55d– | 55d– | 644d– | n/a– |
Trading data
SURI | ETF 2 | |
Last sale 10/28/2026 at 1:30 PM | $17.00 | – |
| Previous close 10/27/2026 | $16.84 | – |
| Consolidated volume 10/27/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Advertisement
Main metrics
Last update 10/28/2026 at 1:30 PM
Live
Closed
SURI | ETF 2 | |
|---|---|---|
| Last price | $17.00 | – |
| 1D performance | +0.96% | – |
| AuM | $74.05 M | – |
| E/R | 2.82% | – |
Characteristics
SURI | ETF 2 | |
|---|---|---|
| Management strategy | Active | – |
| Provider | Simplify | – |
| Benchmark | - | – |
| N° of holdings | 26 | – |
| Asset class | - | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | February 7, 2023 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
SURI
USA
82.26%
Other
17.74%
ETF 2
Sectors
SURI
Healthcare
50.73%
Energy
39.62%
Other
9.65%
ETF 2
Advertisement
Diversification
SURI
Total weight of top 15 holdings out of 15
89.26%
ETF 2
–
Top 15 holdings
Data as of August 31, 2026
SURI
Plains GP Holdings LP
39.62%
Achieve Life Sciences, Inc.
13.42%
US0044681874
5.73%
Delcath Systems, Inc.
4.89%
Milestone Pharmaceuticals, Inc.
4.45%
Corcept Therapeutics, Inc.
3.75%
Collegium Pharmaceutical, Inc.
2.55%
Phathom Pharmaceuticals, Inc.
2.52%
Abeona Therapeutics, Inc.
1.97%
Compass Pathways Plc
1.95%
Celldex Therapeutics, Inc.
1.89%
Kyverna Therapeutics, Inc.
1.85%
Inventiva SA
1.69%
Aquestive Therapeutics, Inc.
1.62%
LeonaBio, Inc.
1.37%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Advertisement
